YD Bio Ltd - YDES

Sector: Healthcare · Industry: Biotechnology
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$1.061M
QoQ value delta ($000)
+$427K (+67.35%)
Implied price effect (QoQ)
+70.28%
Shares
Total shares
279,483
QoQ shares delta
-4,886 (-1.72%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (YDES)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Garrett Wealth Advisory Group, LLC 627 84,630 0.1%
GEODE CAPITAL MANAGEMENT, LLC 141 62,714 0.0%
Cypress Capital Management LLC (WY) 75 33,690 0.06%
Cerity Partners LLC 72 32,406 0.0%
CITADEL ADVISORS LLC 67 30,106 0.0%
JANE STREET GROUP, LLC 48 21,423 0.0%
UBS Group AG 27 12,384 0.0%
SkyView Investment Advisors, LLC 4 1,777 0.0%
WELLS FARGO & COMPANY/MN 0 75 0.0%
FMR LLC 0 1 0.0%
MORGAN STANLEY 0 160 0.0%
ROYAL BANK OF CANADA 0 117 0.0%